Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
7.69
+0.29 (3.92%)
At close: Jun 26, 2026, 4:00 PM EDT
7.66
-0.03 (-0.39%)
After-hours: Jun 26, 2026, 7:49 PM EDT
Xeris Biopharma Holdings Market Cap
Xeris Biopharma Holdings has a market cap or net worth of $1.33 billion as of June 26, 2026. Its market cap has increased by 89.26% in one year.
Market Cap
1.33B
Enterprise Value
1.47B
1-Year Change
89.26%
Ranking
Category
Stock Price
$7.69
Market Cap Chart
Since October 6, 2021, Xeris Biopharma Holdings's market cap has increased from $295.78M to $1.33B, an increase of 348.86%. That is a compound annual growth rate of 37.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 1.33B | 1.93% |
| Dec 31, 2025 | 1.30B | 157.72% |
| Dec 31, 2024 | 505.39M | 55.70% |
| Dec 29, 2023 | 324.59M | 79.47% |
| Dec 30, 2022 | 180.86M | -50.50% |
| Dec 31, 2021 | 365.40M | 23.54% |
| Oct 6, 2021 | 295.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bausch Health Companies | 1.78B |
| Trulieve Cannabis | 1.73B |
| Harrow | 1.57B |
| Perrigo Company | 1.38B |
| Phibro Animal Health | 1.29B |
| Alvotech | 1.24B |
| Collegium Pharmaceutical | 1.19B |
| BioAge Labs | 1.06B |